# Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC

> **NCT01401517** · PHASE2 · COMPLETED · sponsor: **TheraVasc Inc.** · enrollment: 55 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** sodium nitrite

## Key facts

- **NCT ID:** NCT01401517
- **Lead sponsor:** TheraVasc Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401517, "Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01401517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*